scholarly journals Seroprevalence of human T-cell lymphotropic virus I and II (HTLV I/II) among blood donors in a public blood center of Sergipe State, northeastern Brazil

Author(s):  
Cibele Macedo Santos ◽  
◽  
Rafael de Souza Aguiar ◽  
Ester Bencz ◽  
Vanessa Oliveira Amorim ◽  
...  
Author(s):  
Waleska Mayara Gomes de Lima ◽  
Fabrício Andrade Martins Esteves ◽  
Maria do Carmo Morais Rodrigues Torres ◽  
Edna Suely Feitosa Pires

2010 ◽  
Vol 43 (6) ◽  
pp. 615-619 ◽  
Author(s):  
Maria Regina Dias-Bastos ◽  
Cláudia Di Lorenzo Oliveira ◽  
Anna Bárbara de Freitas Carneiro-Proietti

INTRODUCTION: Human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) are endemic in Brazil and are screened for in transfusion services since 1993. This study evaluated the evolution of the prevalence of HTLV-1 and 2 in blood donors of the Hemominas Foundation from 1993 to 2007, and its geographical distribution in State of Minas Gerais, Brazil. METHODS: The Hemominas Foundation is a centralized blood center in Minas Gerais, Brazil. The sources of data were the Hemominas Foundation Technical Bulletin and files from the centralized serological laboratory. Donors were tested in the period using enzyme linked immuno sorbent assays (ELISA), followed by Western blot, when repeatedly reactive. The data were analyzed by EPIINFO 6.2 and TABWIN 3.5 softwares. RESULTS: The average seroprevalence in the period 1993-2007 was 0.1%. A steady decline occurred from 0.4% in 1993 to below 0.1% in 2002 and later, with a transient peak of 0.5% in 1994. HTLV reactivity distribution was asymmetrical in the state, with regions of higher prevalence, interspersed with low prevalence areas. Comparison of positive and negative donors verified that increasing age was proportional to virus positivity. Odds ratio for age ranged from 1.43 (30 to 39 years-old) to 3.09 (50 to 65 years-old). Women had a greater chance of being positive (OR-1.64), as previously described. CONCLUSIONS: Possible explanations for HTLV-1/2 prevalence decline are the exclusion of positive donors from the donor pool, an increase in repeat donors and ELISA test improvement, with reduction in the number of false positive results.


2000 ◽  
Vol 95 (5) ◽  
pp. 711-712 ◽  
Author(s):  
Pedro P Chieffi ◽  
Carlos S Chiattone ◽  
Elder N Feltrim ◽  
Rita CS Alves ◽  
Maria A Paschoalotti

2009 ◽  
Vol 65 (1) ◽  
pp. 38-40 ◽  
Author(s):  
CN Chaudhari ◽  
T Shah ◽  
RN Misra

Transfusion ◽  
2020 ◽  
Vol 60 (7) ◽  
pp. 1483-1491
Author(s):  
Jill‐Léa Ramassamy ◽  
Olivier Cassar ◽  
Manoushka Toumbiri ◽  
Abdoulaye Diané ◽  
Antony Idam Mamimandjiami ◽  
...  

2015 ◽  
pp. 31 ◽  
Author(s):  
Robinson Onoh ◽  
Augustine Okoye ◽  
Godswill Obed Ibegbulam ◽  
Ngozi Immaculata Ugwu ◽  
Chukwudi Siemon Anigbo ◽  
...  

1997 ◽  
Vol 57 (2) ◽  
pp. 142-148 ◽  
Author(s):  
Aluisio A. C. Segurado ◽  
Claudio S. Pannuti ◽  
Renu B. Lal ◽  
Laura M. Sumita ◽  
Ceila M. S. Malaque

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Patience Uchenna Tweteise ◽  
Bernard Natukunda ◽  
Joel Bazira

Background. The human T-cell lymphotropic virus types 1 and 2 (HTLV 1/2) are retroviruses associated with different pathologies. HTLV-1 causes adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP); HTLV-2 is not clearly associated with a known clinical disease. Both viruses may be transmitted by whole blood transfusion, from mother to child predominantly through breastfeeding, and by sexual contact. Presently, none of the regional blood banks in Uganda perform routine pretransfusion screening for HTLV. The aim of this study was to determine the prevalence of anti-human T-cell lymphotropic virus types 1/2 (HTLV-1/2) antibodies among blood donors at Mbarara Regional Blood Bank in South Western Uganda. A cross-sectional study was conducted between June 2014 and September 2014. Methodology. Consecutive blood samples of 368 blood donors were screened for anti-HTLV-1/2 antibodies using an enzyme linked immunosorbent assay (ELISA). Samples reactive on a first HTLV-1/2 ELISA were further retested in duplicate using the same ELISA. Of the three hundred and sixty-eight blood donors (229 (62.2%) males and 139 (37.8%) females), only two male donors aged 20 and 21 years were HTLV-1/2 seropositive, representing a prevalence of 0.54%. Conclusion. HTLV-1/2 prevalence is low among blood donors at Mbarara Regional Blood Bank. Studies among other categories of people at risk for HTLV 1/2 infection should be carried out.


2010 ◽  
Vol 199 (4) ◽  
pp. 341-344 ◽  
Author(s):  
Luis Chandía ◽  
Cristina Sotomayor ◽  
Sylvia Ordenes ◽  
Pilar Salas ◽  
Maritza Navarrete ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document